| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |